Dianthus Therapeutics | MGTA - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 1.72B 185M 2026-06
Neuren Pharmaceuticals AUD 4.23M 1.68M 2025-12
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.13B 16M 2026-06
Pharma Mar EUR 19.34M 29.53M 2026-06
Qiagen NV USD 646.29M 192.72M 2026-03
Revvity USD 1.02B 162.62M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 886.5M 917.7M 2026-06
Xeris Pharmaceuticals USD 121.75M 10M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03